Components:
Method of action:
Treatment option:
Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Viral hepatitis, asphyxia (including newborns), pneumonia, asthmatic conditions, coronary heart disease, senile retinal degeneration, intoxication.
IV or IV (drip), iv 4-8 ml 1-2 times a day for 10-14 days, for heart diseases IV drip at a rate of 30-40 drops/min for 6-8 hours (daily dose 12-32 ml) (4-8 ml of the drug is dissolved in 200 ml of isotonic sodium chloride solution or 5% glucose solution), in the postoperative period IV 4 ml 2 times a day, with asphyxia of newborns in the umbilical vein in the first 2 minutes after birth at a dose of 4 ml, with bronchial asthma in/m 2-4 ml 2 times a day for 14-25 days.
Hypersensitivity.
Chills, hyperthermia (with rapid injection into a vein).
- Antihypoxants and antioxidants
In a dry place, protected from light, at a temperature of 4-20 °C.
Keep out of reach of children.
Shelf life of the drug Cytochrome C2 года.Do not use after the expiration date indicated on the package.
Instructions for medical useCytochrome C
Instructions for medical use-RU no. LP-000631
Last modified date: 22.12.2016
Dosage form
Eye drops
Composition
1 ml of the drug contains:
Active ingredient:
Cytochrome C1 -2.5 mg
Excipients:
sodium chloride, water for injection.
1 Obtained from the hearts of cattle, horses, and pigs.
Description of the dosage form
Transparent reddish-brown liquid
Pharmacological Group
Metabolic agent
Pharmacological (immuno-biological) properties
A metabolic agent, it has an antihypoxic, trophic effect, stimulates the regeneration processes. It is a catalyst for cellular respiration.
Pharmacodynamics
The mechanism of action of the drug is associated with the presence of iron in the prosthetic group, which can pass from the oxidized state to the reduced state. As a result, endogenous redox reactions and metabolic processes in tissues are accelerated, and oxygen utilization is improved.
Pharmacokinetics
When applied topically, Cytochrome C is not absorbed into the systemic bloodstream, but is completely metabolized in the body. The breakdown of cytochrome C follows the same metabolic pathways as the breakdown of amino acids, and heme, broken down to bilirubin, is excreted in the bile.
Indications
As part of complex therapy for corneal dystrophy (primary and secondary), corneal opacification, keratitis (at the stage of epithelialization).
Contraindications
Children under 18 years of age. Hypersensitivity to the components of the drug. Pregnancy and the breastfeeding period.
Method of administration and dosage
Locally. 1-2 drops in the conjunctival sac 3-4 times a day.
The duration of use of the drug as part of complex therapy is determined by the attending physician, depending on the effectiveness of therapy.
Side effects
Allergic reactions, conjunctival hyperemia, short-term burning sensation in the eye.
Overdose
No data available.
Interaction
Interaction studies have not been conducted.
Special instructions
When using other ophthalmic medications at the same time, the interval between their administration should be at least 10-15 minutes.
Influence on the ability to drive vehicles and mechanisms
Patients who have a short-term burning sensation of the eyes after instillation of the drug should not drive vehicles and mechanisms immediately after applying eye drops.
Release form
Eye drops 0.25%.
2 ml each in glass bottles with a capacity of 5 ml, capped with rubber stoppers and rolled with aluminum caps.
1 bottle with a cap-dropper and instructions for medical use of the drug is placed in a pack of cardboard box.
Storage conditions
In a place protected from light at a temperature of 4 to 20°C.
The opened bottle should be stored in the refrigerator for no more than 3 days in a closed form.
Keep out of reach of children.
Expiration date
2 years.
Do not use after the expiration date.
Conditions of supply of pharmacies
Without a prescription.
1 bottle contains 4 ml of 0.25% solution for injection, in a package of 10 pcs.
C01CX Other Cardiotonic drugs
- B15-B19 Viral hepatitis
- H30-H36 Diseases of the choroid and retina
- I25 Chronic Coronary heart disease
- J18 Pneumonia without specifying the causative agent
- J45 Asthma
- R06 Abnormal breathing
- T40 Poisoning by drugs and psychodysleptics [hallucinogens]
- T51 Toxic effects of alcohol
